Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Aabha Oza; Michael P. Rettig; Phil Powell; Kathryn O'Brien; David B. Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A. Fehniger; Christopher A. Miller; Patrick Soon-Shiong; Amy Rock; John F. DiPersio

doi:10.1182/bloodadvances.2019000664

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O'Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	2387-2391
Number of pages	5
Journal	Blood Advances
Volume	4
Issue number	11
DOIs	https://doi.org/10.1182/bloodadvances.2019000664
State	Published - Jun 9 2020

Access to Document

10.1182/bloodadvances.2019000664

Cite this

Oza, A., Rettig, M. P., Powell, P., O'Brien, K., Clifford, D. B., Ritchey, J., Gehrs, L., Hollaway, J., Major, E., Fehniger, T. A., Miller, C. A., Soon-Shiong, P., Rock, A., & DiPersio, J. F. (2020). Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient. Blood Advances, 4(11), 2387-2391. https://doi.org/10.1182/bloodadvances.2019000664

@article{11ea2330174a4dab874a892ad3613aa7,

title = "Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient",

author = "Aabha Oza and Rettig, {Michael P.} and Phil Powell and Kathryn O'Brien and Clifford, {David B.} and Julie Ritchey and Leah Gehrs and Julia Hollaway and Eugene Major and Fehniger, {Todd A.} and Miller, {Christopher A.} and Patrick Soon-Shiong and Amy Rock and DiPersio, {John F.}",

note = "Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA091842).",

year = "2020",

month = jun,

day = "9",

doi = "10.1182/bloodadvances.2019000664",

language = "English",

volume = "4",

pages = "2387--2391",

journal = "Blood Advances",

issn = "2473-9529",

number = "11",

}

Oza, A, Rettig, MP, Powell, P, O'Brien, K, Clifford, DB, Ritchey, J, Gehrs, L, Hollaway, J, Major, E, Fehniger, TA , Miller, CA, Soon-Shiong, P, Rock, A & DiPersio, JF 2020, 'Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient', Blood Advances, vol. 4, no. 11, pp. 2387-2391. https://doi.org/10.1182/bloodadvances.2019000664

TY - JOUR

T1 - Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

AU - Oza, Aabha

AU - Rettig, Michael P.

AU - Powell, Phil

AU - O'Brien, Kathryn

AU - Clifford, David B.

AU - Ritchey, Julie

AU - Gehrs, Leah

AU - Hollaway, Julia

AU - Major, Eugene

AU - Fehniger, Todd A.

AU - Miller, Christopher A.

AU - Soon-Shiong, Patrick

AU - Rock, Amy

AU - DiPersio, John F.

N1 - Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). Funding Information: This work was supported by a NIH National Cancer Institute (NCI) Outstanding Investigator Award (R35 CA210084) (J.F.D.), NCI Research Specialist Awards (R50 CA211466 [M.P.R.] and R50 CA211782 [C.A.M.]), and an NCI grant (R01 CA171963) (T.A.F.). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant (P30 CA091842).

PY - 2020/6/9

Y1 - 2020/6/9

UR - http://www.scopus.com/inward/record.url?scp=85088408636&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2019000664

DO - 10.1182/bloodadvances.2019000664

M3 - Article

C2 - 32484854

AN - SCOPUS:85088408636

SN - 2473-9529

VL - 4

SP - 2387

EP - 2391

JO - Blood Advances

JF - Blood Advances

IS - 11

ER -

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Access to Document

Other files and links

Cite this